nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.264	0.565	CbGaD
Trimipramine—HTR2A—chronic obstructive pulmonary disease	0.203	0.435	CbGaD
Trimipramine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0341	0.101	CbGbCtD
Trimipramine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0341	0.101	CbGbCtD
Trimipramine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0284	0.0842	CbGbCtD
Trimipramine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0284	0.0842	CbGbCtD
Trimipramine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.026	0.077	CbGbCtD
Trimipramine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.026	0.077	CbGbCtD
Trimipramine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0231	0.0686	CbGbCtD
Trimipramine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0218	0.0646	CbGbCtD
Trimipramine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0215	0.0638	CbGbCtD
Trimipramine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0147	0.0436	CbGbCtD
Trimipramine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0143	0.0425	CbGbCtD
Trimipramine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.014	0.0416	CbGbCtD
Trimipramine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0125	0.0371	CbGbCtD
Trimipramine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0122	0.0363	CbGbCtD
Trimipramine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0116	0.0343	CbGbCtD
Trimipramine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00734	0.0218	CbGbCtD
Trimipramine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00693	0.0206	CbGbCtD
Trimipramine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00626	0.312	CbGeAlD
Trimipramine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00227	0.113	CbGeAlD
Trimipramine—HTR3A—respiratory system—chronic obstructive pulmonary disease	0.000947	0.0472	CbGeAlD
Trimipramine—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.000788	0.0393	CbGeAlD
Trimipramine—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000722	0.036	CbGeAlD
Trimipramine—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000677	0.0338	CbGeAlD
Trimipramine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	0.000636	0.0317	CbGeAlD
Trimipramine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000579	0.0289	CbGeAlD
Trimipramine—HTR3A—lung—chronic obstructive pulmonary disease	0.000503	0.0251	CbGeAlD
Trimipramine—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000487	0.00459	CcSEcCtD
Trimipramine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000487	0.00459	CcSEcCtD
Trimipramine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000478	0.00451	CcSEcCtD
Trimipramine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000477	0.0045	CcSEcCtD
Trimipramine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000474	0.00447	CcSEcCtD
Trimipramine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.00442	CcSEcCtD
Trimipramine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000469	0.00442	CcSEcCtD
Trimipramine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00046	0.00433	CcSEcCtD
Trimipramine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000458	0.0228	CbGeAlD
Trimipramine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.00431	CcSEcCtD
Trimipramine—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.00431	CcSEcCtD
Trimipramine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000453	0.00427	CcSEcCtD
Trimipramine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000451	0.00425	CcSEcCtD
Trimipramine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000448	0.00422	CcSEcCtD
Trimipramine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000442	0.00417	CcSEcCtD
Trimipramine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000435	0.0041	CcSEcCtD
Trimipramine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000435	0.0041	CcSEcCtD
Trimipramine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000433	0.00408	CcSEcCtD
Trimipramine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000427	0.00403	CcSEcCtD
Trimipramine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000425	0.00401	CcSEcCtD
Trimipramine—Petechiae—Prednisone—chronic obstructive pulmonary disease	0.000425	0.004	CcSEcCtD
Trimipramine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.00395	CcSEcCtD
Trimipramine—SLC6A3—lung—chronic obstructive pulmonary disease	0.000418	0.0209	CbGeAlD
Trimipramine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000415	0.00392	CcSEcCtD
Trimipramine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000413	0.00389	CcSEcCtD
Trimipramine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00383	CcSEcCtD
Trimipramine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000403	0.0201	CbGeAlD
Trimipramine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00378	CcSEcCtD
Trimipramine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00376	CcSEcCtD
Trimipramine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00376	CcSEcCtD
Trimipramine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000397	0.00374	CcSEcCtD
Trimipramine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000397	0.00374	CcSEcCtD
Trimipramine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000396	0.0197	CbGeAlD
Trimipramine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000394	0.00371	CcSEcCtD
Trimipramine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000393	0.00371	CcSEcCtD
Trimipramine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.0037	CcSEcCtD
Trimipramine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000393	0.0037	CcSEcCtD
Trimipramine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000391	0.00369	CcSEcCtD
Trimipramine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000391	0.00368	CcSEcCtD
Trimipramine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00367	CcSEcCtD
Trimipramine—SLC6A4—lung—chronic obstructive pulmonary disease	0.000383	0.0191	CbGeAlD
Trimipramine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00361	CcSEcCtD
Trimipramine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000382	0.0191	CbGeAlD
Trimipramine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.00358	CcSEcCtD
Trimipramine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00038	0.00358	CcSEcCtD
Trimipramine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000376	0.00355	CcSEcCtD
Trimipramine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00355	CcSEcCtD
Trimipramine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000371	0.0035	CcSEcCtD
Trimipramine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.00037	0.0184	CbGeAlD
Trimipramine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000368	0.0184	CbGeAlD
Trimipramine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.00345	CcSEcCtD
Trimipramine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00343	CcSEcCtD
Trimipramine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00343	CcSEcCtD
Trimipramine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.00341	CcSEcCtD
Trimipramine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00036	0.0034	CcSEcCtD
Trimipramine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.0034	CcSEcCtD
Trimipramine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00338	CcSEcCtD
Trimipramine—Benazepril—ACE—chronic obstructive pulmonary disease	0.000358	0.072	CrCbGaD
Trimipramine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00336	CcSEcCtD
Trimipramine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00336	CcSEcCtD
Trimipramine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00336	CcSEcCtD
Trimipramine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000355	0.00335	CcSEcCtD
Trimipramine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000352	0.00332	CcSEcCtD
Trimipramine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.0033	CcSEcCtD
Trimipramine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00035	0.0033	CcSEcCtD
Trimipramine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000349	0.00329	CcSEcCtD
Trimipramine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000346	0.00326	CcSEcCtD
Trimipramine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00324	CcSEcCtD
Trimipramine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000343	0.00323	CcSEcCtD
Trimipramine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000343	0.00323	CcSEcCtD
Trimipramine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00321	CcSEcCtD
Trimipramine—HRH1—trachea—chronic obstructive pulmonary disease	0.000338	0.0169	CbGeAlD
Trimipramine—SLC6A2—lung—chronic obstructive pulmonary disease	0.000338	0.0168	CbGeAlD
Trimipramine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00318	CcSEcCtD
Trimipramine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000336	0.0168	CbGeAlD
Trimipramine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000336	0.00317	CcSEcCtD
Trimipramine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000336	0.00316	CcSEcCtD
Trimipramine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.00316	CcSEcCtD
Trimipramine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000335	0.00316	CcSEcCtD
Trimipramine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000332	0.0166	CbGeAlD
Trimipramine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000331	0.00312	CcSEcCtD
Trimipramine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00312	CcSEcCtD
Trimipramine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000329	0.00311	CcSEcCtD
Trimipramine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000329	0.00311	CcSEcCtD
Trimipramine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000329	0.00311	CcSEcCtD
Trimipramine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000329	0.0031	CcSEcCtD
Trimipramine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000329	0.0031	CcSEcCtD
Trimipramine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00308	CcSEcCtD
Trimipramine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00308	CcSEcCtD
Trimipramine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.00305	CcSEcCtD
Trimipramine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.00305	CcSEcCtD
Trimipramine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000323	0.00305	CcSEcCtD
Trimipramine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000323	0.00304	CcSEcCtD
Trimipramine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000317	0.00299	CcSEcCtD
Trimipramine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000317	0.00299	CcSEcCtD
Trimipramine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00298	CcSEcCtD
Trimipramine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000312	0.00294	CcSEcCtD
Trimipramine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00293	CcSEcCtD
Trimipramine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00031	0.00293	CcSEcCtD
Trimipramine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00031	0.00293	CcSEcCtD
Trimipramine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00292	CcSEcCtD
Trimipramine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00292	CcSEcCtD
Trimipramine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00291	CcSEcCtD
Trimipramine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000308	0.0153	CbGeAlD
Trimipramine—DRD2—lung—chronic obstructive pulmonary disease	0.000308	0.0153	CbGeAlD
Trimipramine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00288	CcSEcCtD
Trimipramine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00286	CcSEcCtD
Trimipramine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.00282	CcSEcCtD
Trimipramine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00279	CcSEcCtD
Trimipramine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00279	CcSEcCtD
Trimipramine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000295	0.00278	CcSEcCtD
Trimipramine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00275	CcSEcCtD
Trimipramine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000287	0.0027	CcSEcCtD
Trimipramine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.0027	CcSEcCtD
Trimipramine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.00269	CcSEcCtD
Trimipramine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00269	CcSEcCtD
Trimipramine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00267	CcSEcCtD
Trimipramine—HTR2A—trachea—chronic obstructive pulmonary disease	0.000282	0.0141	CbGeAlD
Trimipramine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00266	CcSEcCtD
Trimipramine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00266	CcSEcCtD
Trimipramine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00265	CcSEcCtD
Trimipramine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00264	CcSEcCtD
Trimipramine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00263	CcSEcCtD
Trimipramine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00263	CcSEcCtD
Trimipramine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00263	CcSEcCtD
Trimipramine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00262	CcSEcCtD
Trimipramine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000276	0.0026	CcSEcCtD
Trimipramine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000275	0.0026	CcSEcCtD
Trimipramine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00259	CcSEcCtD
Trimipramine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000273	0.00258	CcSEcCtD
Trimipramine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.00258	CcSEcCtD
Trimipramine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000273	0.00258	CcSEcCtD
Trimipramine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00255	CcSEcCtD
Trimipramine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00255	CcSEcCtD
Trimipramine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00255	CcSEcCtD
Trimipramine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00253	CcSEcCtD
Trimipramine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00252	CcSEcCtD
Trimipramine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00251	CcSEcCtD
Trimipramine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.0025	CcSEcCtD
Trimipramine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000265	0.0025	CcSEcCtD
Trimipramine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00249	CcSEcCtD
Trimipramine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00249	CcSEcCtD
Trimipramine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00248	CcSEcCtD
Trimipramine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00248	CcSEcCtD
Trimipramine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.00247	CcSEcCtD
Trimipramine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.00247	CcSEcCtD
Trimipramine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00246	CcSEcCtD
Trimipramine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00246	CcSEcCtD
Trimipramine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000261	0.00246	CcSEcCtD
Trimipramine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00245	CcSEcCtD
Trimipramine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00245	CcSEcCtD
Trimipramine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00243	CcSEcCtD
Trimipramine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00241	CcSEcCtD
Trimipramine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000252	0.00237	CcSEcCtD
Trimipramine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000252	0.00237	CcSEcCtD
Trimipramine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00236	CcSEcCtD
Trimipramine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00236	CcSEcCtD
Trimipramine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00236	CcSEcCtD
Trimipramine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00236	CcSEcCtD
Trimipramine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00025	0.0125	CbGeAlD
Trimipramine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00025	0.00235	CcSEcCtD
Trimipramine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00234	CcSEcCtD
Trimipramine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00233	CcSEcCtD
Trimipramine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00233	CcSEcCtD
Trimipramine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000247	0.00233	CcSEcCtD
Trimipramine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00232	CcSEcCtD
Trimipramine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00232	CcSEcCtD
Trimipramine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.00232	CcSEcCtD
Trimipramine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00231	CcSEcCtD
Trimipramine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00231	CcSEcCtD
Trimipramine—HRH1—lung—chronic obstructive pulmonary disease	0.000243	0.0121	CbGeAlD
Trimipramine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000239	0.0119	CbGeAlD
Trimipramine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00224	CcSEcCtD
Trimipramine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00223	CcSEcCtD
Trimipramine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00223	CcSEcCtD
Trimipramine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000233	0.0022	CcSEcCtD
Trimipramine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.000228	0.0457	CrCbGaD
Trimipramine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00214	CcSEcCtD
Trimipramine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00214	CcSEcCtD
Trimipramine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00211	CcSEcCtD
Trimipramine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00211	CcSEcCtD
Trimipramine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000223	0.0021	CcSEcCtD
Trimipramine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00207	CcSEcCtD
Trimipramine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00204	CcSEcCtD
Trimipramine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00204	CcSEcCtD
Trimipramine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00203	CcSEcCtD
Trimipramine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00202	CcSEcCtD
Trimipramine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000212	0.002	CcSEcCtD
Trimipramine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.002	CcSEcCtD
Trimipramine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.000211	0.0425	CrCbGaD
Trimipramine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00198	CcSEcCtD
Trimipramine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00198	CcSEcCtD
Trimipramine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00193	CcSEcCtD
Trimipramine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00193	CcSEcCtD
Trimipramine—HTR2A—lung—chronic obstructive pulmonary disease	0.000203	0.0101	CbGeAlD
Trimipramine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000202	0.0019	CcSEcCtD
Trimipramine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.0019	CcSEcCtD
Trimipramine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000201	0.0019	CcSEcCtD
Trimipramine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00188	CcSEcCtD
Trimipramine—Rash—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00188	CcSEcCtD
Trimipramine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00188	CcSEcCtD
Trimipramine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00188	CcSEcCtD
Trimipramine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00188	CcSEcCtD
Trimipramine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00187	CcSEcCtD
Trimipramine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00187	CcSEcCtD
Trimipramine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.00187	CcSEcCtD
Trimipramine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00187	CcSEcCtD
Trimipramine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00186	CcSEcCtD
Trimipramine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00184	CcSEcCtD
Trimipramine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00184	CcSEcCtD
Trimipramine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00184	CcSEcCtD
Trimipramine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00183	CcSEcCtD
Trimipramine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00182	CcSEcCtD
Trimipramine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.000192	0.0385	CrCbGaD
Trimipramine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00181	CcSEcCtD
Trimipramine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000192	0.00181	CcSEcCtD
Trimipramine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.00179	CcSEcCtD
Trimipramine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00179	CcSEcCtD
Trimipramine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00178	CcSEcCtD
Trimipramine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00178	CcSEcCtD
Trimipramine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000188	0.00177	CcSEcCtD
Trimipramine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000188	0.00177	CcSEcCtD
Trimipramine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00177	CcSEcCtD
Trimipramine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000185	0.00923	CbGeAlD
Trimipramine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00174	CcSEcCtD
Trimipramine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00172	CcSEcCtD
Trimipramine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000181	0.00171	CcSEcCtD
Trimipramine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000178	0.0358	CrCbGaD
Trimipramine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00168	CcSEcCtD
Trimipramine—Epinastine—HTR2A—chronic obstructive pulmonary disease	0.000177	0.0356	CrCbGaD
Trimipramine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00167	CcSEcCtD
Trimipramine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00165	CcSEcCtD
Trimipramine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00162	CcSEcCtD
Trimipramine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00158	CcSEcCtD
Trimipramine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000163	0.00154	CcSEcCtD
Trimipramine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00148	CcSEcCtD
Trimipramine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00146	CcSEcCtD
Trimipramine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00146	CcSEcCtD
Trimipramine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00145	CcSEcCtD
Trimipramine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00136	CcSEcCtD
Trimipramine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00134	CcSEcCtD
Trimipramine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00133	CcSEcCtD
Trimipramine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00014	0.00132	CcSEcCtD
Trimipramine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000138	0.0013	CcSEcCtD
Trimipramine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00129	CcSEcCtD
Trimipramine—Mianserin—SLC6A4—chronic obstructive pulmonary disease	0.000133	0.0268	CrCbGaD
Trimipramine—ABCB1—lung—chronic obstructive pulmonary disease	0.000133	0.00663	CbGeAlD
Trimipramine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00125	CcSEcCtD
Trimipramine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00124	CcSEcCtD
Trimipramine—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	0.000132	0.0265	CrCbGaD
Trimipramine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00122	CcSEcCtD
Trimipramine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00121	CcSEcCtD
Trimipramine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00118	CcSEcCtD
Trimipramine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.000123	0.0248	CrCbGaD
Trimipramine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000122	0.0245	CrCbGaD
Trimipramine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00115	CcSEcCtD
Trimipramine—Mianserin—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.0244	CrCbGaD
Trimipramine—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000119	0.0239	CrCbGaD
Trimipramine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00112	CcSEcCtD
Trimipramine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.00107	CcSEcCtD
Trimipramine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00106	CcSEcCtD
Trimipramine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00106	CcSEcCtD
Trimipramine—Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.000112	0.0224	CrCbGaD
Trimipramine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.0223	CrCbGaD
Trimipramine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00103	CcSEcCtD
Trimipramine—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.0218	CrCbGaD
Trimipramine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00102	CcSEcCtD
Trimipramine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00102	CcSEcCtD
Trimipramine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00102	CcSEcCtD
Trimipramine—Desipramine—ADRB2—chronic obstructive pulmonary disease	0.000108	0.0217	CrCbGaD
Trimipramine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00101	CcSEcCtD
Trimipramine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00101	CcSEcCtD
Trimipramine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	0.000107	0.0215	CrCbGaD
Trimipramine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00101	CcSEcCtD
Trimipramine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000969	CcSEcCtD
Trimipramine—Mianserin—HTR2A—chronic obstructive pulmonary disease	0.000102	0.0206	CrCbGaD
Trimipramine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000961	CcSEcCtD
Trimipramine—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.0202	CrCbGaD
Trimipramine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	9.98e-05	0.0201	CrCbGaD
Trimipramine—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.9e-05	0.000934	CcSEcCtD
Trimipramine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000929	CcSEcCtD
Trimipramine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.86e-05	0.000929	CcSEcCtD
Trimipramine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	9.85e-05	0.0198	CrCbGaD
Trimipramine—Desipramine—SLC6A4—chronic obstructive pulmonary disease	9.81e-05	0.0197	CrCbGaD
Trimipramine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	9.73e-05	0.0196	CrCbGaD
Trimipramine—Methadone—CYP1A2—chronic obstructive pulmonary disease	9.68e-05	0.0195	CrCbGaD
Trimipramine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	9.37e-05	0.0188	CrCbGaD
Trimipramine—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	9.16e-05	0.0184	CrCbGaD
Trimipramine—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.95e-05	0.000843	CcSEcCtD
Trimipramine—Desipramine—CYP1A2—chronic obstructive pulmonary disease	8.93e-05	0.0179	CrCbGaD
Trimipramine—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.000832	CcSEcCtD
Trimipramine—Promazine—CYP1A2—chronic obstructive pulmonary disease	8.65e-05	0.0174	CrCbGaD
Trimipramine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000804	CcSEcCtD
Trimipramine—Acepromazine—ALB—chronic obstructive pulmonary disease	8.43e-05	0.0169	CrCbGaD
Trimipramine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	8.43e-05	0.0169	CrCbGaD
Trimipramine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	8.32e-05	0.0167	CrCbGaD
Trimipramine—Promethazine—HTR2A—chronic obstructive pulmonary disease	8.3e-05	0.0167	CrCbGaD
Trimipramine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	8.27e-05	0.0166	CrCbGaD
Trimipramine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000777	CcSEcCtD
Trimipramine—Doxepin—HTR2A—chronic obstructive pulmonary disease	8.22e-05	0.0165	CrCbGaD
Trimipramine—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.93e-05	0.000747	CcSEcCtD
Trimipramine—Rash—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.000741	CcSEcCtD
Trimipramine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.00074	CcSEcCtD
Trimipramine—Headache—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000736	CcSEcCtD
Trimipramine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	7.61e-05	0.0153	CrCbGaD
Trimipramine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	7.58e-05	0.0152	CrCbGaD
Trimipramine—Desipramine—HTR2A—chronic obstructive pulmonary disease	7.54e-05	0.0151	CrCbGaD
Trimipramine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	7.53e-05	0.0151	CrCbGaD
Trimipramine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.41e-05	0.000698	CcSEcCtD
Trimipramine—Promazine—HTR2A—chronic obstructive pulmonary disease	7.3e-05	0.0147	CrCbGaD
Trimipramine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	6.43e-05	0.0129	CrCbGaD
Trimipramine—Clomipramine—ALB—chronic obstructive pulmonary disease	6.41e-05	0.0129	CrCbGaD
Trimipramine—Imipramine—HTR2A—chronic obstructive pulmonary disease	6.39e-05	0.0128	CrCbGaD
Trimipramine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	6.35e-05	0.0128	CrCbGaD
Trimipramine—Nortriptyline—ALB—chronic obstructive pulmonary disease	6.27e-05	0.0126	CrCbGaD
Trimipramine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	4.4e-05	0.00884	CrCbGaD
Trimipramine—Amitriptyline—ALB—chronic obstructive pulmonary disease	4.35e-05	0.00874	CrCbGaD
Trimipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.12e-05	0.000173	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.12e-05	0.000173	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.12e-05	0.000173	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.11e-05	0.000171	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.1e-05	0.00017	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.09e-05	0.000169	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.09e-05	0.000168	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.08e-05	0.000167	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.08e-05	0.000166	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.07e-05	0.000165	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.06e-05	0.000163	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.03e-05	0.000159	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.03e-05	0.000159	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.02e-05	0.000158	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.01e-05	0.000157	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.01e-05	0.000156	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.01e-05	0.000156	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1e-05	0.000155	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1e-05	0.000155	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.93e-06	0.000153	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.93e-06	0.000153	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	9.89e-06	0.000153	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.86e-06	0.000152	CbGpPWpGaD
Trimipramine—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	9.82e-06	0.000152	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.79e-06	0.000151	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.77e-06	0.000151	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.76e-06	0.000151	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.71e-06	0.00015	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.68e-06	0.00015	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.66e-06	0.000149	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.66e-06	0.000149	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.64e-06	0.000149	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.52e-06	0.000147	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.36e-06	0.000145	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.34e-06	0.000144	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.29e-06	0.000143	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.23e-06	0.000143	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.22e-06	0.000142	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.22e-06	0.000142	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.21e-06	0.000142	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.18e-06	0.000142	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.17e-06	0.000142	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.13e-06	0.000141	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.12e-06	0.000141	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.1e-06	0.000141	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.05e-06	0.00014	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.03e-06	0.000139	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.02e-06	0.000139	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	9e-06	0.000139	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.86e-06	0.000137	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.82e-06	0.000136	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.81e-06	0.000136	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.8e-06	0.000136	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.78e-06	0.000136	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.76e-06	0.000135	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.68e-06	0.000134	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.57e-06	0.000132	CbGpPWpGaD
Trimipramine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.56e-06	0.000132	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.53e-06	0.000132	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.52e-06	0.000132	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.5e-06	0.000131	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.47e-06	0.000131	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.44e-06	0.00013	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.43e-06	0.00013	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.43e-06	0.00013	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.41e-06	0.00013	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.41e-06	0.00013	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.38e-06	0.000129	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.37e-06	0.000129	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.35e-06	0.000129	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.32e-06	0.000128	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.3e-06	0.000128	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.29e-06	0.000128	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.25e-06	0.000127	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.23e-06	0.000127	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.19e-06	0.000127	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.16e-06	0.000126	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.12e-06	0.000125	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.07e-06	0.000125	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.91e-06	0.000122	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.88e-06	0.000122	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.84e-06	0.000121	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.78e-06	0.00012	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.73e-06	0.000119	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.67e-06	0.000118	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.65e-06	0.000118	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.65e-06	0.000118	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.64e-06	0.000118	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.61e-06	0.000118	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.6e-06	0.000117	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.59e-06	0.000117	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.58e-06	0.000117	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.5e-06	0.000116	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.5e-06	0.000116	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	7.45e-06	0.000115	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.45e-06	0.000115	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.44e-06	0.000115	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.3e-06	0.000113	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.17e-06	0.000111	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.02e-06	0.000108	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.96e-06	0.000108	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.94e-06	0.000107	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.92e-06	0.000107	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.92e-06	0.000107	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.84e-06	0.000106	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.8e-06	0.000105	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.79e-06	0.000105	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.77e-06	0.000105	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.71e-06	0.000104	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.68e-06	0.000103	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.67e-06	0.000103	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.66e-06	0.000103	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.66e-06	0.000103	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.48e-06	0.0001	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.44e-06	9.95e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.4e-06	9.89e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.38e-06	9.85e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.38e-06	9.84e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.35e-06	9.8e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.33e-06	9.77e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.29e-06	9.72e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.24e-06	9.63e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.22e-06	9.61e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.19e-06	9.56e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.18e-06	9.54e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.17e-06	9.52e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.15e-06	9.49e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.11e-06	9.44e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.04e-06	9.33e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.02e-06	9.29e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.95e-06	9.19e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.9e-06	9.11e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.9e-06	9.11e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.89e-06	9.09e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.87e-06	9.06e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.86e-06	9.05e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.81e-06	8.98e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	5.8e-06	8.95e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.7e-06	8.8e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.69e-06	8.78e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.62e-06	8.68e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.59e-06	8.64e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.58e-06	8.62e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.56e-06	8.58e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	5.55e-06	8.56e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.51e-06	8.51e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.48e-06	8.46e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.43e-06	8.38e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.43e-06	8.38e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.42e-06	8.37e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.34e-06	8.25e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.33e-06	8.23e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.23e-06	8.08e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.23e-06	8.08e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.23e-06	8.07e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.21e-06	8.04e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.18e-06	8e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.16e-06	7.96e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.13e-06	7.92e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.1e-06	7.87e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.09e-06	7.86e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.09e-06	7.85e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5e-06	7.72e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.99e-06	7.71e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.98e-06	7.7e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.98e-06	7.69e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.95e-06	7.65e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.9e-06	7.57e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.86e-06	7.5e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.74e-06	7.32e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.73e-06	7.31e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.71e-06	7.27e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.64e-06	7.16e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.6e-06	7.1e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.52e-06	6.98e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.51e-06	6.97e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.51e-06	6.96e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.43e-06	6.84e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.4e-06	6.8e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.37e-06	6.75e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.31e-06	6.65e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.3e-06	6.64e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.29e-06	6.63e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.25e-06	6.56e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.23e-06	6.53e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.21e-06	6.5e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.17e-06	6.44e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.16e-06	6.42e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.11e-06	6.35e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.11e-06	6.35e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.11e-06	6.34e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.09e-06	6.32e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.08e-06	6.3e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.05e-06	6.25e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.04e-06	6.24e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.01e-06	6.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4e-06	6.18e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.96e-06	6.12e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.94e-06	6.09e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.93e-06	6.07e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.91e-06	6.04e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.9e-06	6.03e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.88e-06	5.99e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.84e-06	5.92e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.83e-06	5.92e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.83e-06	5.91e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.81e-06	5.88e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.78e-06	5.83e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.75e-06	5.78e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.73e-06	5.76e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.72e-06	5.75e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.72e-06	5.74e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.67e-06	5.67e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.66e-06	5.66e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.64e-06	5.63e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.63e-06	5.61e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.61e-06	5.58e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.6e-06	5.55e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.58e-06	5.53e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.43e-06	5.29e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.37e-06	5.21e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.36e-06	5.19e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.36e-06	5.19e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.34e-06	5.16e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.33e-06	5.14e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.31e-06	5.1e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.3e-06	5.1e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.3e-06	5.09e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.24e-06	5e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.21e-06	4.96e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.2e-06	4.93e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.07e-06	4.74e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.06e-06	4.72e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.05e-06	4.7e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.01e-06	4.64e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.94e-06	4.54e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.93e-06	4.52e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.82e-06	4.36e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.8e-06	4.32e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.78e-06	4.29e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.77e-06	4.28e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.72e-06	4.2e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.58e-06	3.99e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.54e-06	3.92e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.53e-06	3.91e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.52e-06	3.9e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.49e-06	3.84e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.47e-06	3.81e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.36e-06	3.65e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.31e-06	3.57e-05	CbGpPWpGaD
